- Report
- March 2024
- 185 Pages
Asia Pacific
€4962EUR$4,995USD£4,126GBP
- Report
- May 2023
- 391 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- July 2021
Global
From €943EUR$949USD£784GBP
- Report
- July 2021
- 290 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- November 2021
- 209 Pages
Global
From €4222EUR$4,250USD£3,510GBP
- Report
- November 2024
Global
From €300EUR$323USD£258GBP
- Report
- November 2024
Global
From €400EUR$431USD£344GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,426USD£1,936GBP
- Report
- July 2021
- 259 Pages
Global
From €2150EUR$2,318USD£1,850GBP
- Report
- May 2023
- 187 Pages
Global
From €4917EUR$5,123USD£3,950GBP
- Report
- October 2023
- 470 Pages
Global
From €2782EUR$2,800USD£2,313GBP
- Drug Pipelines
- August 2023
- 400 Pages
China
From €2980EUR$3,000USD£2,478GBP
- Drug Pipelines
- August 2023
- 580 Pages
United States
From €4172EUR$4,200USD£3,469GBP
- Report
- May 2023
- 1500 Pages
China
From €5067EUR$5,100USD£4,213GBP
- Report
- May 2022
- 330 Pages
Global
From €2980EUR$3,000USD£2,478GBP
- Report
- May 2022
- 510 Pages
Global
From €2980EUR$3,000USD£2,478GBP
- Report
- February 2022
- 360 Pages
United States
From €3576EUR$3,600USD£2,974GBP
- Report
- February 2021
- 100 Pages
Global
From €1987EUR$2,000USD£1,652GBP
- Report
- June 2022
- 124 Pages
Global
From €5464EUR$5,500USD£4,543GBP
- Report
- March 2023
- 64 Pages
Global
From €2484EUR$2,500USD£2,065GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more